IN THE NEWS
June 26, 2017:
Avenue Therapeutics Prices Initial Public Offering of $33,000,000 of Common Stock
June 26, 2017:
Checkpoint Therapeutics Commences Trading on the NASDAQ Capital Market
June 15, 2017:
Fortress Biotech to Present at the 2017 BIO International Convention
June 5, 2017:
Fortress Biotech Announces that its Subsidiary, Mustang Bio, Enters into License Agreements with City of Hope for Novel CAR T Immunotherapies
June 1, 2017:
Checkpoint Therapeutics to Present at the Jefferies 2017 Global Healthcare Conference
June 1, 2017:
Fortress Biotech Subsidiary Caelum Biosciences Enters Biopharmaceutical Manufacturing Agreement with Patheon
QUICK LINKS
PIPELINE
